A health economics researcher explains why purchase price is the smallest number in a clinical trial technology decision and what gets left off the budget.
- Research Design Mistakes Even Experienced Analysts Still Make
- The Infrastructure Behind Virtua Health's Push Toward 1.5 Million Studies A Year
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Your EDC Query Count Is Trying To Tell You Something
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How A Remote ePRO Solution Helped Reduce Patient Burden
Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.
-
Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, And Integrations
Dive into six insights to stay on top of the rapidly shifting research industry and to ensure your research organization doesn’t get left behind.
-
How Technology Can Empower CAR T-Cell Therapy Clinical Trials
Explore how innovative technologies are pushing advancements in CAR T-cell therapy, enhancing patient outcomes, and streamlining trial processes.
-
How Optina Diagnostics Used EDC In Earlier Disease Detection
Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.
-
Enhancing Participant Payments: A New Approach
Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
C3 Summit Recap: Shaping The Future Of eCOA/ePRO Highlights
Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.
-
What's Trending In The Biopharma And Biotech Industries
With improved access to affordable digital technologies and a regulatory emphasis on diversity in patient recruitment, check out several highlights of the most notable projections in 2023.
-
The Advantages Of DCTs In Diabetes Research
By harnessing technology platforms, discover how researchers can be better equipped to design studies for novel diabetes treatments that are safer, more efficient, and more effective.
-
Patient Caregiver Network Improves Post-Seizure Trial Data
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Analyzing The FDA's Approach To Diversity In Clinical Trials
Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
- The Hidden Costs Of Clinical Trial Technology Nobody Budgets For
- What South Africa's Trial Sites Teach Global Clinical Research
- Research Design Mistakes Even Experienced Analysts Still Make
- The Infrastructure Behind Virtua Health's Push Toward 1.5 Million Studies A Year
- A Framework For Deploying AI In Clinical Trials Without The Hype
RECENT NEWSLETTERS
- 10.22.26 -- AI, RWE, And IRT Are Exposing Trial Workforce Gaps
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials